$MYGN
MYRIAD GENETICS INC Stock $mygn

$mygn Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000089992321000090 Filed on November 04, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$160.8M	$167.3M	$145.2M
YoY Change	4.01%	15.22%	-22.06%
Cost Of Revenue	$45.80M	$47.80M	$44.20M
YoY Change	-2.97%	8.14%	-11.07%
Gross Profit	$115.0M	$119.5M	$101.0M
YoY Change	7.08%	18.32%	-26.06%
Gross Profit Margin	71.52%	71.43%	69.56%
Selling, General & Admin	$77.30M	$180.2M	$124.1M
YoY Change	-41.79%	45.21%	-8.41%
% of Gross Profit	67.22%	150.79%	122.87%
Research & Development	$20.50M	$18.80M	$17.60M
YoY Change	12.64%	6.82%	-17.37%
% of Gross Profit	17.83%	15.73%	17.43%
Depreciation & Amortization	$13.30M	$2.600M	$2.400M
YoY Change	-26.52%	8.33%	-17.24%
% of Gross Profit	11.57%	2.18%	2.38%
Operating Expenses	$96.10M	$199.0M	$141.7M
YoY Change	-38.24%	40.44%	-9.63%
Operating Profit	$18.90M	-$79.90M	-$39.60M
YoY Change	-139.21%	101.77%	89.47%
Interest Expense	-$400.0K	$1.100M	$2.900M
YoY Change	-84.62%	-62.07%	0.0%
% of Operating Profit	-2.12%
Other Income/Expense, Net	$0.00	$119.7M	-$4.100M
YoY Change	-100.0%	-3019.51%	192.86%
Pretax Income	-$43.50M	$39.80M	-$43.70M
YoY Change	-13.69%	-191.08%	95.96%
Income Tax	-$35.90M	$15.20M	-$28.50M
% Of Pretax Income		38.19%
Net Earnings	-$7.600M	$24.60M	-$15.20M
YoY Change	-79.95%	-261.84%	-26.21%
Net Earnings / Revenue	-4.73%	14.7%	-10.47%
Basic Earnings Per Share		$0.31	-$0.20
Diluted Earnings Per Share	-$94.88K	$0.30	-$0.20
COMMON SHARES
Basic Shares Outstanding	79.85M shares	78.80M shares	74.70M shares
Diluted Shares Outstanding		81.50M shares	74.70M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$339.8M	$366.1M	$160.4M
YoY Change	125.48%	128.24%	12.48%
Cash & Equivalents	$258.4M	$295.2M	$118.3M
Short-Term Investments	$81.40M	$70.90M	$42.10M
Other Short-Term Assets	$38.40M	$20.60M	$120.4M
YoY Change	-68.03%	-82.89%	225.41%
Inventory	$15.30M	$18.60M	$26.60M
Prepaid Expenses
Receivables	$91.30M	$93.60M	$85.10M
Other Receivables	$0.00	$0.00	$2.000M
Total Short-Term Assets	$484.8M	$498.9M	$394.5M
YoY Change	24.5%	26.46%	19.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$43.50M	$43.40M	$36.70M
YoY Change	6.88%	18.26%	-33.27%
Goodwill	$239.2M	$239.7M	$328.3M
YoY Change	-27.34%	-26.99%	-21.1%
Intangibles	$404.1M	$414.8M	$590.9M
YoY Change	-29.9%	-29.8%	-11.52%
Long-Term Investments	$59.00M	$47.50M	$30.20M
YoY Change	180.95%	57.28%	-41.36%
Other Assets	$8.300M	$8.000M	$1.200M
YoY Change	260.87%	566.67%
Total Long-Term Assets	$835.9M	$837.0M	$1.050B
YoY Change	-18.8%	-20.29%	-16.78%
TOTAL ASSETS
Total Short-Term Assets	$484.8M	$498.9M	$394.5M
Total Long-Term Assets	$835.9M	$837.0M	$1.050B
Total Assets	$1.321B	$1.336B	$1.445B
YoY Change	-6.91%	-7.52%	-9.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$29.60M	$15.70M	$19.10M
YoY Change	44.39%	-17.8%	-20.42%
Accrued Expenses	$156.5M	$163.2M	$65.40M
YoY Change	97.85%	149.54%	-10.41%
Deferred Revenue	$5.200M	$11.50M	$32.30M
YoY Change	-84.1%	-64.4%	1438.1%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$204.3M	$203.2M	$133.7M
YoY Change	40.03%	51.98%	15.86%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$224.6M
YoY Change	-100.0%	-100.0%	-0.18%
Other Long-Term Liabilities	$5.600M	$10.80M	$10.70M
YoY Change	-61.9%	0.93%	46.58%
Total Long-Term Liabilities	$5.600M	$10.80M	$10.70M
YoY Change	-97.66%	0.93%	-95.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$204.3M	$203.2M	$133.7M
Total Long-Term Liabilities	$5.600M	$10.80M	$10.70M
Total Liabilities	$352.9M	$367.4M	$535.2M
YoY Change	-34.38%	-31.35%	3.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$254.2M	-$246.6M	-$189.1M
YoY Change	11.98%	30.41%
Common Stock	$1.227B	$1.220B	$1.102B
YoY Change	10.52%	10.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$967.8M	$968.6M	$909.3M
YoY Change
Total Liabilities & Shareholders Equity	$1.321B	$1.336B	$1.445B
YoY Change	-6.91%	-7.52%	-9.22%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$7.600M	$24.60M	-$15.20M
YoY Change	-79.95%	-261.84%	-26.21%
Depreciation, Depletion And Amortization	$13.30M	$2.600M	$2.400M
YoY Change	-26.52%	8.33%	-17.24%
Cash From Operating Activities	-$9.900M	-$39.30M	-$59.30M
YoY Change	-31.25%	-33.73%	-475.32%
INVESTING ACTIVITIES
Capital Expenditures	-$3.400M	-$3.000M	-$1.500M
YoY Change	-46.88%	100.0%	7.14%
Acquisitions
YoY Change
Other Investing Activities	-$22.50M	$294.0M	$18.60M
YoY Change	-230.06%	1480.65%	-426.32%
Cash From Investing Activities	-$25.90M	$291.0M	$17.10M
YoY Change	-337.61%	1601.75%	-340.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.100M	-74.50M	-$3.900M
YoY Change	-161.11%	1810.26%	-68.29%
NET CHANGE
Cash From Operating Activities	-9.900M	-39.30M	-$59.30M
Cash From Investing Activities	-25.90M	291.0M	$17.10M
Cash From Financing Activities	-1.100M	-74.50M	-$3.900M
Net Change In Cash	-36.90M	177.2M	-$45.40M
YoY Change	2070.59%	-490.31%	1275.76%
FREE CASH FLOW
Cash From Operating Activities	-$9.900M	-$39.30M	-$59.30M
Capital Expenditures	-$3.400M	-$3.000M	-$1.500M
Free Cash Flow	-$6.500M	-$36.30M	-$57.80M
YoY Change	-18.75%	-37.2%	-436.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0000899923
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-26642
	dei	Entity Registrant Name EntityRegistrantName	MYRIAD GENETICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line1 EntityAddressAddressLine1	320 Wakara Way
	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0494517
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84108
	dei	City Area Code CityAreaCode	801
	dei	Local Phone Number LocalPhoneNumber	584-3600
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	MYGN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	79854649	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	295200000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117000000.0	USD
CY2021Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	70900000	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	33700000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	93600000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	89500000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	18600000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	27100000	USD
CY2021Q3	us-gaap	Prepaid Taxes PrepaidTaxes	400000	USD
CY2020Q4	us-gaap	Prepaid Taxes PrepaidTaxes	108400000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20200000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13700000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	498900000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	389400000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	83600000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	59700000	USD
CY2021Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	47500000	USD
CY2020Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	21000000.0	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43400000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40700000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	414800000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	576500000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	239700000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	329200000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8000000.0	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2300000	USD
CY2021Q3	us-gaap	Assets Assets	1335900000	USD
CY2020Q4	us-gaap	Assets Assets	1418800000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	15700000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20500000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	163200000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	79100000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12800000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13600000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11500000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	32700000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	203200000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	145900000	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	32000000.0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	30500000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	40700000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	71300000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	80700000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	50600000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	224800000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10800000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14700000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	367400000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	537800000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79700000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75400000	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	800000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	800000	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1218800000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1109500000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4400000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2300000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-246600000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-227000000.0	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	968600000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	881000000.0	USD
CY2021Q3	us-gaap	Minority Interest MinorityInterest	-100000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	0	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	968500000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	881000000.0	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1335900000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1418800000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	167300000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	145200000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	529800000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	402400000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18800000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17600000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61400000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	54700000	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	180200000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	124100000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	460500000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	364400000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	400000	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1100000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1700000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-4500000	USD
CY2021Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2020Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	1800000	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	98400000	USD
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	247200000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	184800000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	677200000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	644000000.0	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-79900000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-39600000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-147400000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-241600000	USD
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	200000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	400000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	600000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1700000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	1100000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	2900000	USD
	us-gaap	Interest Expense InterestExpense	6100000	USD
	us-gaap	Interest Expense InterestExpense	8300000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	120600000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1600000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	139300000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14900000	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	119700000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4100000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	133800000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8300000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	39800000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43700000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13600000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-233300000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15200000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-28500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000000.0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-47400000	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	24600000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-15200000	USD
	us-gaap	Profit Loss ProfitLoss	-19600000	USD
	us-gaap	Profit Loss ProfitLoss	-185900000	USD
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	24600000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-15200000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-185800000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Inventory Firm Purchase Commitment Loss InventoryFirmPurchaseCommitmentLoss	5200000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.49
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.49
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78800000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74700000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77300000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74600000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81500000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74700000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74600000	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	24600000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-15200000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19600000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	6500000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-185800000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-200000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-200000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-500000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	500000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-200000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1800000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1600000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1100000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	24200000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13600000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-21700000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-184200000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	24200000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13600000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21700000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-184200000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1077300000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	200000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7500000	USD
CY2020Q1	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-100000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-115200000	USD
CY2020Q1	mygn	Reclassification From Accumulated Other Comprehensive Loss Deconsolidation Of Subsidiary ReclassificationFromAccumulatedOtherComprehensiveLossDeconsolidationOfSubsidiary	100000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2600000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	967200000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1900000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1900000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-55400000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2600000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	918200000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-3700000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8400000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-15200000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1600000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	909300000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	881000000.0	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	26000000.0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9000000.0	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-39500000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1300000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	875200000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	23500000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8900000	USD
CY2021Q2	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-100000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-4700000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-400000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	902400000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	31900000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10000000.0	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	24600000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-400000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	968500000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-185800000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	49500000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	53300000	USD
	mygn	Non Cash Interest Expense NonCashInterestExpense	1300000	USD
	mygn	Non Cash Interest Expense NonCashInterestExpense	400000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	9800000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	9600000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	27900000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	17800000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	27800000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	600000	USD
	mygn	Increase Decrease In Unrecognized Tax Benefits IncreaseDecreaseInUnrecognizedTaxBenefits	1500000	USD
	mygn	Increase Decrease In Unrecognized Tax Benefits IncreaseDecreaseInUnrecognizedTaxBenefits	14900000	USD
	mygn	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	1700000	USD
	mygn	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-4500000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	6500000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	mygn	Impairment Of Goodwill And Long Lived Assets Held For Use ImpairmentOfGoodwillAndLongLivedAssetsHeldForUse	1800000	USD
	mygn	Impairment Of Goodwill And Long Lived Assets Held For Use ImpairmentOfGoodwillAndLongLivedAssetsHeldForUse	98400000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	162000000.0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1000000.0	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	6700000	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-5400000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11600000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-33300000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1600000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1700000	USD
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-108000000.0	USD
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	83200000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3600000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1200000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4800000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2600000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	78200000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3100000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-20400000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	28500000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	28100000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12500000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	14600000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	6800000	USD
	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	379100000	USD
	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	21300000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	101000000.0	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	15800000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	36800000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	51900000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	300300000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	50600000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	90000000.0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2200000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8600000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3900000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	3300000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	100000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1200000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1000000.0	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	226400000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-149500000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2800000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-700000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	300000	USD
	mygn	Net Change In Cash And Cash Equivalents Classified As Held For Sale NetChangeInCashAndCashEquivalentsClassifiedAsHeldForSale	0	USD
	mygn	Net Change In Cash And Cash Equivalents Classified As Held For Sale NetChangeInCashAndCashEquivalentsClassifiedAsHeldForSale	1500000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	178200000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	37100000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117000000.0	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81200000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295200000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118300000	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the total assets, total liabilities, stockholders’ equity, cash flows from operations, or net income (loss) for the period.</span></div>
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	167300000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	145200000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	529800000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	402400000	USD
CY2020	mygn	Cares Act Of2020 Medicare Payment Amount CARESActOf2020MedicarePaymentAmount	29700000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	32700000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3600000	USD
	mygn	Contract With Customer Liability Including New Contract Revenue Recognized ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized	30300000	USD
	mygn	Contract With Customer Liability Including New Contract Revenue Recognized ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized	8400000	USD
	mygn	Contract With Customer Liability Prepayments ContractWithCustomerLiabilityPrepayments	10100000	USD
	mygn	Contract With Customer Liability Prepayments ContractWithCustomerLiabilityPrepayments	37100000	USD
	mygn	Contract With Customer Liability Divestitures ContractWithCustomerLiabilityDivestitures	1000000.0	USD
	mygn	Contract With Customer Liability Divestitures ContractWithCustomerLiabilityDivestitures	0	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11500000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	32300000	USD
CY2021Q3	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	7600000	USD
	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	16600000	USD
CY2021Q1	mygn	Contract With Customer Asset Adjustment To Revenue For Expanded Coverage Previously Constrained ContractWithCustomerAssetAdjustmentToRevenueForExpandedCoveragePreviouslyConstrained	6800000	USD
CY2021Q3	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	0	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	295200000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	295200000	USD
CY2021Q3	mygn	Investments And Cash Amortized Cost InvestmentsAndCashAmortizedCost	413400000	USD
CY2021Q3	mygn	Investments And Cash Accumulated Gross Unrealized Gain Before Tax InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax	300000	USD
CY2021Q3	mygn	Investments And Cash Accumulated Gross Unrealized Loss Before Tax InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax	100000	USD
CY2021Q3	us-gaap	Investments And Cash InvestmentsAndCash	413600000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117000000.0	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	117000000.0	USD
CY2020Q4	mygn	Investments And Cash Amortized Cost InvestmentsAndCashAmortizedCost	170900000	USD
CY2020Q4	mygn	Investments And Cash Accumulated Gross Unrealized Gain Before Tax InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax	800000	USD
CY2020Q4	mygn	Investments And Cash Accumulated Gross Unrealized Loss Before Tax InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Investments And Cash InvestmentsAndCash	171700000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	70700000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	70900000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	47500000	USD
CY2021Q3	us-gaap	Depreciation Depreciation	2600000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	47500000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	0	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	0	USD
CY2021Q3	mygn	Investments And Cash Amortized Cost InvestmentsAndCashAmortizedCost	413400000	USD
CY2021Q3	us-gaap	Investments And Cash InvestmentsAndCash	413600000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	0	security
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	0	security
CY2021Q3	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	196000000.0	USD
CY2020Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	112900000	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	10900000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	3300000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-1700000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	500000	USD
CY2021Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8800000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	148400000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	153600000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	105000000.0	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	112900000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43400000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40700000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	2400000	USD
	us-gaap	Depreciation Depreciation	8900000	USD
	us-gaap	Depreciation Depreciation	7500000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	329200000	USD
	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	88500000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1000000.0	USD
CY2021Q3	us-gaap	Goodwill Goodwill	239700000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	617400000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	202600000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	414800000	USD
CY2021Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	617400000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	202600000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	414800000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	825900000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	254200000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	571700000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	4800000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	4800000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	830700000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	254200000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	576500000	USD
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11600000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15300000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	40600000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	45800000	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	54000000.0	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	48900000	USD
CY2021Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	48000000.0	USD
CY2020Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	USD
CY2021Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	17300000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4300000	USD
CY2021Q3	mygn	Refunds Payable And Reserve Current RefundsPayableAndReserveCurrent	8900000	USD
CY2020Q4	mygn	Refunds Payable And Reserve Current RefundsPayableAndReserveCurrent	9300000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3300000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3400000	USD
CY2021Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	5000000.0	USD
CY2020Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3800000	USD
CY2021Q3	us-gaap	Recorded Unconditional Purchase Obligation RecordedUnconditionalPurchaseObligation	5200000	USD
CY2020Q4	us-gaap	Recorded Unconditional Purchase Obligation RecordedUnconditionalPurchaseObligation	0	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	21500000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9400000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	163200000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	79100000	USD
CY2021Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	48000000	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	0	USD
CY2021Q3	mygn	Other Assets Debt Discount OtherAssetsDebtDiscount	1800000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	224800000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	1900000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	5500000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	7400000	USD
CY2021Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	5300000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	7300000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10800000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14700000	USD
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79700000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79700000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75400000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75400000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	74500000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	74500000	shares
	mygn	Stock Issued During Period Shares Share Based Payment Arrangement And Employee Stock Purchase Plans StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans	4300000	shares
	mygn	Stock Issued During Period Shares Share Based Payment Arrangement And Employee Stock Purchase Plans StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans	700000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79700000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79700000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75200000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75200000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4900000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78800000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74700000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77300000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74600000	shares
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2700000	shares
CY2020Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81500000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74700000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74600000	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7300000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.57
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7300000	shares
CY2021Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	110700000	USD
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0	shares
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5200000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.24
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3600000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	24.26
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	100000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	25.03
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1500000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1100000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	23.20
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2600000	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10000000.0	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8400000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27900000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17800000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15200000	USD
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.382
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-28500000	USD
CY2020Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.652
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.441
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-47400000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.203
CY2021Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	48000000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	167300000	USD
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14200000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-79900000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	145200000	USD
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17700000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-39600000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	529800000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	49500000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-147400000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	402400000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	53300000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-241600000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-79900000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-39600000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-147400000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-241600000	USD
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	200000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	400000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	600000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1700000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	1100000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	2900000	USD
	us-gaap	Interest Expense InterestExpense	6100000	USD
	us-gaap	Interest Expense InterestExpense	8300000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	120600000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1600000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	139300000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14900000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	39800000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43700000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13600000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-233300000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15200000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-28500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000000.0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-47400000	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	24600000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-15200000	USD
	us-gaap	Profit Loss ProfitLoss	-19600000	USD
	us-gaap	Profit Loss ProfitLoss	-185900000	USD
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	24600000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-15200000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-185800000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2400000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2300000	USD
	us-gaap	Interest Paid Net InterestPaidNet	2100000	USD
	us-gaap	Interest Paid Net InterestPaidNet	6900000	USD
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	89900000	USD
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	40500000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	mygn	Operating Lease Liability Established OperatingLeaseLiabilityEstablished	46800000	USD
	mygn	Operating Lease Liability Established OperatingLeaseLiabilityEstablished	0	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	120600000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	139300000	USD

Files In Submission

Name	View Source	Status
0000899923-21-000090-index-headers.html	Edgar Link	pending
0000899923-21-000090-index.html	Edgar Link	pending
0000899923-21-000090.txt	Edgar Link	pending
0000899923-21-000090-xbrl.zip	Edgar Link	pending
exhibit101-amendedandresta.htm	Edgar Link	pending
exhibit311-certificationof.htm	Edgar Link	pending
exhibit312-certificationof.htm	Edgar Link	pending
exhibit321-certificationpu.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mygn-20210930.htm	Edgar Link	pending
mygn-20210930.xsd	Edgar Link	pending
mygn-20210930_cal.xml	Edgar Link	unprocessable
mygn-20210930_def.xml	Edgar Link	unprocessable
mygn-20210930_htm.xml	Edgar Link	completed
mygn-20210930_lab.xml	Edgar Link	unprocessable
mygn-20210930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MYGN
MYRIAD GENETICS INC Stock $mygn

2021 Q4 Form 10-Q Financial Statement

#000089992321000090 Filed on November 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYGN MYRIAD GENETICS INC Stock $mygn

2021 Q4 Form 10-Q Financial Statement

#000089992321000090 Filed on November 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYGN
MYRIAD GENETICS INC Stock $mygn